Item 7.01. Regulation FD Disclosure.
As previously announced, on March 25, 2022, Oscar Health, Inc. (the “Company”) will host a virtual investor day conference (the “Conference”), beginning at 9:00 a.m. Eastern Time. At the Conference, the Company will reconfirm its full year 2022 guidance as issued in its 2021 financial results press release dated February 10, 2022, and make other forward-looking statements relating to its strategic plans, long-term growth targets and levers available to achieve these targets. There will be a live webcast of the Conference accessible via the Company’s investor relations website at https://ir.hioscar.com. Instructions for accessing the webcast were previously provided by a news wire release on March 7, 2022 and can also be found on the Company’s investor relations website. A copy of the materials to be presented by the Company at the Conference will be available on the Company’s investor relations website shortly before the Conference begins.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing.
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our expected financial performance and upcoming events and presentations. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control. Although management believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the Securities and Exchange Commission (“SEC”), and our other filings with the SEC. You are cautioned not to place undue reliance on any forward-looking statements made herein. Any forward-looking statement speaks only as of the date as of which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise.
